Serial allometric factor extrapolation: compartmental and physiological pharmacokinetic approaches

Area of Science:

• Pharmacokinetics and Toxicology
• Allometry and Dose-Response Modeling

Background:

• Interspecies dose-response equivalence is commonly estimated using simple scaling ratios based on physiological parameters like body weight.
• This traditional approach is often insufficient for many applications due to its inability to account for complex toxicological mechanisms.

Purpose of the Study:

• To introduce and demonstrate a structured approach for dose scaling, termed serial allometric factor extrapolation (SAFE).
• To address the limitations of current methods by incorporating chemical-specific toxic interaction mechanisms into the dose scaling process.

Main Methods:

• Developed the serial allometric factor extrapolation (SAFE) procedure, a novel structured approach to dose scaling.
• Applied SAFE using published data on acute intravenous toxicity of chemotherapeutic agents in animals and humans.
• Utilized compartmental and physiological pharmacokinetic (PPK) modeling as the basis for SAFE.

Main Results:

• Demonstrated the biological plausibility and utility of the SAFE procedure for interspecies dose scaling.
• Showcased how SAFE can incorporate chemical-specific toxic mechanisms, improving accuracy over simpler methods.
• Illustrated the interrelationships between SAFE, PPK, and regression allometry in dose-response analysis.

Conclusions:

• The SAFE procedure offers a more robust and biologically relevant method for interspecies dose scaling compared to traditional approaches.
• Incorporating toxic interaction mechanisms via SAFE enhances the prediction of dose-response relationships across species.
• SAFE provides a valuable framework for pharmacokinetic and toxicological research, particularly for drug development and risk assessment.